Patients with keratoconus are constantly seeking the best treatment for their eyes. Many of those dealing with keratoconus feel that the treatment they have received thus far has been unsatisfactory. What can keratoconus patients expect for 2007?
FDA trials are already underway and past the early stages in a variety of vision related trials. Early results for C3-R treatment have been promising but this treatment has not yet been FDA approved. There are several surgeons who perform C3-R treatment off-label but thus far it is not yet endorsed by the US FDA. We will likely see further results at Ophthalmological Seminars regarding the efficacy of this treatment.
Contact lens treatments for keratoconus are also advancing and increased research in this area can be expected in 2007. Synergeyes offers a new hybrid lens for keratoconus patients and so far results with this treatment have been excellent. We can expect more keratoconus patients to be fit with the newer hybrid lenses (a blend of hard and soft lenses). As practitioners gain more skill in fitting these lenses, we can expect results to continue to improve.
The Help Keratoconus blog will continue to offer new information in 2007 and continue to provide new findings concerning keratoconus as well as offer new options in treatment. Continue to visit the blog on a monthly or biweekly basis as new blogs try to offer the newest insights into keratoconus.